A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations - ScienceDirect
Genetik der Antikörpervielfalt - lernen mit den Eselsbrücken von Meditricks
Immunoglobulin Free Light Chains Kappa and Lambda Human ELISA | RD194088100R